Status:
UNKNOWN
A Registry of Peripartum Cardiomyopathy in Turkey
Lead Sponsor:
Ege University
Collaborating Sponsors:
Turkish Society of Cardiology
Conditions:
Peripartum Cardiomyopathy
Eligibility:
FEMALE
18-60 years
Brief Summary
Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retros...
Detailed Description
Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retros...
Eligibility Criteria
Inclusion
- Patient above 18 years of age
- Unexplained Heart Failure symptoms developed towards the end of pregnancy or in the first 6 months of postpartum period
- Ejection fraction less than 45% documented with echocardiography
Exclusion
- Patients with any other known cardiac pathology
Key Trial Info
Start Date :
July 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 15 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03364140
Start Date
July 2 2017
End Date
January 15 2018
Last Update
December 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Koc University Medical School Cardiology Department
Istanbul, Turkey (Türkiye)